DBV Technologies to Report First Half 2021 Financial Results and Business Updates on August 2, 2021
26 Juillet 2021 - 10:30PM
Montrouge, France, July 26, 2021
DBV Technologies to Report First Half 2021
Financial Results and Business Updates
on August 2, 2021
DBV Technologies (Euronext: DBV – ISIN:
FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage
biopharmaceutical company, today announced that the Company will
host a conference call and live audio webcast on Monday, August 2,
2021, at 5:00 p.m. ET to report first half 2021 financial results
and provide a corporate update.
This call is accessible via the below
teleconferencing numbers, followed by the reference ID:
50184237.United States:
(866)-939-3921 Canada:
(866)-215-5508United Kingdom: 0808 238
9578 France:
0805 102 604
A live webcast of the call will be available on
the Investors & Media section of the Company’s website:
https://www.dbv-technologies.com/investor-relations/. A replay of
the presentation will also be available on DBV’s website after the
event.
About DBV Technologies DBV
Technologies is developing Viaskin™, an investigational proprietary
technology platform with broad potential applications in
immunotherapy. Viaskin is based on epicutaneous immunotherapy, or
EPIT™, DBV’s method of delivering biologically active compounds to
the immune system through intact skin. With this new class of
non-invasive product candidates, the Company is dedicated to safely
transforming the care of food allergic patients. DBV’s food
allergies programs include ongoing clinical trials of Viaskin
Peanut. DBV Technologies has global headquarters in Montrouge,
France, and North American operations in Summit, NJ. The Company’s
ordinary shares are traded on segment B of Euronext Paris (Ticker:
DBV, ISIN code: FR0010417345), part of the SBF120 index, and the
Company’s ADSs (each representing one-half of one ordinary share)
are traded on the Nasdaq Global Select Market (Ticker: DBVT).
Investor Contact Anne PollakDBV
Technologies+1 857-529-2363anne.pollak@dbv-technologies.com
Media ContactAngela MarcucciDBV
Technologies+1 646-842-2393angela.marcucci@dbv-technologies.com
DBV Technologies (EU:DBV)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
DBV Technologies (EU:DBV)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024